Related Experiment Video

Updated: Sep 13, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

685

Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells

Georg Bündgen1, Alexander Ulges1, Jan Pietruschka1

  • 1University Medical Center Mainz, Institute of Immunology, 55131 Mainz, Germany.

Immunity
|August 1, 2025
PubMed

Insights

Tumor metabolism influences regulatory T (Treg) cells. Inhibiting polyamines or protein kinase CK2 in Treg cells promotes antitumor immunity and tissue repair, offering a novel cancer therapy strategy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Metabolic Regulation

Background:

  • Cancer metabolic changes impact antitumor immunity.
  • Regulatory T (Treg) cells are immunosuppressive and involved in tissue homeostasis.
  • The molecular control of Treg cell function by tumor metabolism is unclear.

Purpose of the Study:

  • To investigate how tumor microenvironment polyamines influence Treg cell function.
  • To determine the role of protein kinase CK2 (CK2) in Treg cell polarization.
  • To explore the therapeutic potential of modulating Treg cell function in cancer.

Main Methods:

  • Analysis of Treg cell polarization in the tumor microenvironment.
  • Investigating the effects of polyamine levels on Treg cells.
  • Utilizing genetic and pharmacological inhibition of CK2 in Treg cells.
  • Assessing immune responses and tissue repair mechanisms.

Main Results:

  • Excessive polyamines in tumors promote Treg cell immunosuppression via CK2.
  • Polyamine deprivation or CK2 inhibition in Treg cells induces tissue reparative functions.
  • Modulated Treg cells orchestrate antitumor type 2 immune responses and support tumor eradication.

Conclusions:

  • Tumor-derived polyamines direct Treg cell immunosuppression through CK2.
  • Targeting polyamine metabolism or CK2 activity in Treg cells can reprogram them for antitumor activity.
  • Modulating Treg cell function represents a promising cancer therapy approach.
Keywords:
FOXP3cancerimmune evasionimmunometabolismkinasemetabolismpolyaminesregulatory T cellstissue repairtumor immunology

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.1K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
4.7K